Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

Area of Science:

• Immunology
• Virology
• Vaccinology

Background:

• Human immunodeficiency virus (HIV) remains a critical global health concern, necessitating effective prevention and treatment strategies.
• Antiretroviral therapy and other interventions exist, but an accessible HIV vaccine is paramount for controlling the epidemic.
• Despite decades of research, HIV vaccine development has encountered significant hurdles, with limited success in clinical trials.

Purpose of the Study:

• To review the historical trajectory of HIV vaccine research and current prevention efforts.
• To emphasize the importance of pre-clinical vaccine development utilizing non-human primate (NHP) models.
• To explore how NHP models inform the design of novel HIV vaccine candidates for human trials.

Main Methods:

• Review of historical HIV vaccine research and clinical trial data.
• Analysis of pre-clinical studies employing non-human primate models of HIV infection.
• Evaluation of insights gained from NHP studies for guiding future vaccine development.

Main Results:

• The development of an effective HIV vaccine is the most critical and cost-efficient strategy to combat the global epidemic.
• Pre-clinical research in NHP models provides essential data for understanding potential preventive mechanisms against HIV.
• NHP models are instrumental in evaluating the safety and immunogenicity of candidate vaccines before human testing.

Conclusions:

• Continued investment in HIV vaccine research, particularly leveraging NHP models, is vital.
• Advancements in pre-clinical research are essential for overcoming challenges in developing a successful HIV vaccine.
• NHP models offer a robust platform for accelerating the development of effective HIV preventive vaccines.